Decision on Paid-in Capital Increase
올릭스
226950
Signal Score
Historical Avg Return (5d)
+0.61%
Data Coverage
100%n=2286
Risk-adjusted indicator based on 2286 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event Type: Paid-in Capital Increase
AI Analysis Summary
OliX Pharmaceuticals, Inc. has announced a decision on a paid-in capital increase. This event typically leads to share dilution, potentially negatively impacting existing shareholder value. The specific terms, such as issuance price, number of new shares, and total funding size, are not available in the provided title-only information, but a capital increase generally suggests a need for funding which could be for R&D, operations, or debt repayment. Without further details, the immediate impact is perceived as negative due to dilution.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.